113 related articles for article (PubMed ID: 30615266)
1. Dysregulation of ß-catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck.
Vyskocil E; Pammer J; Altorjai G; Grasl MC; Parzefall T; Haymerle G; Janik S; Perisanidis C; Erovic BM
Clin Otolaryngol; 2019 May; 44(3):263-272. PubMed ID: 30615266
[TBL] [Abstract][Full Text] [Related]
2. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
3. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy.
Cordes N; Ney M; Beleites T; Aust D; Baretton G; Thames H; Baumann M; Krause M; Löck S; Appold S
PLoS One; 2018; 13(12):e0209479. PubMed ID: 30571736
[TBL] [Abstract][Full Text] [Related]
4. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
6. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
[TBL] [Abstract][Full Text] [Related]
7. WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
Tiefenböck-Hansson K; Haapaniemi A; Farnebo L; Palmgren B; Tarkkanen J; Farnebo M; Munck-Wikland E; Mäkitie A; Garvin S; Roberg K
Oncol Rep; 2017 Oct; 38(4):2062-2068. PubMed ID: 28849066
[TBL] [Abstract][Full Text] [Related]
8. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
Chandrasekara S; Davis S; Thomson P; Haydon A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
[TBL] [Abstract][Full Text] [Related]
9. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
Bădulescu F; Bădulescu A; Crişan A; Popescu FC
Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
[TBL] [Abstract][Full Text] [Related]
10. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.
Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Saito T; Kawamori J; Tanaka Y; Hirotani Y; Homma T
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1221-1229. PubMed ID: 30756227
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes.
Münscher A; Prochnow S; Gulati A; Sauter G; Lörincz B; Blessmann M; Hanken H; Böttcher A; Clauditz TS
Clin Oral Investig; 2019 Jan; 23(1):361-367. PubMed ID: 29671054
[TBL] [Abstract][Full Text] [Related]
13. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
[TBL] [Abstract][Full Text] [Related]
14. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
15. High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer.
Rosenberg V; Pastorekova S; Zatovicova M; Vidlickova I; Jelenska L; Slezak P
Bratisl Lek Listy; 2016; 117(4):201-4. PubMed ID: 27075382
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.
Smilek P; Neuwirthova J; Jarkovsky J; Dusek L; Rottenberg J; Kostrica R; Srovnal J; Hajduch M; Drabek J; Klozar J
Neoplasma; 2012; 59(5):508-15. PubMed ID: 22668015
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
[TBL] [Abstract][Full Text] [Related]
20. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]